Uncategorized Sanofi and GSK Expand Portfolios Through M&A as mRNA Technology Faces Tariff and Funding Challenges – geneonline.com admin June 11, 2025 No Comments Sanofi and GSK Expand Portfolios Through M&A as mRNA Technology Faces Tariff and Funding Challenges geneonline.comsource